Johnson & Johnson New Stent Device Fails in Study

CHICAGO, May 7 (Reuters) - Johnson & Johnson (JNJ.N: Quote, Profile , Research) said on Monday an experimental drug-coated stent failed to meet its primary goal in a study, pushing J&J shares down 1.3 percent before the bell.

>>> Discuss This Story